Chronic pain: Second, do no harm

被引:8
作者
Barbuto, John P. [1 ]
White, George L., Jr. [2 ]
Porucznik, Christina A. [2 ]
Holmes, Edward B. [1 ,3 ]
机构
[1] Univ Utah, Dept Family & Prevent Med, Riverton, UT USA
[2] Univ Utah, Publ Hlth Program, Salt Lake City, UT USA
[3] Utah State Univ, Social Secur Disabil Program, Salt Lake City, UT USA
关键词
pain; evaluation; biopsychosocial; pathophysiology; function; abuse;
D O I
10.1097/PHM.0b013e31815e87b1
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Pain may be undertreated-contributing to anguish, as reported by the World Health Organization. Pain may be overtreated-inadvertently contributing to drug addiction, drug diversion, and even death. Pain may be misunderstood-contributing to illness propagation, as reported in somatization literature. Pain words may even be presented as a tool of manipulation, where report of pain is verbiage in pursuit of utilitarian social consequence. Thus, primum non nocere-first, do no harm-is not easily achieved in the pharmacological treatment of pain, particularly in pain reported chronically. Herein, we examine the pharmacological treatment of chronic pain, and we suggest strategies for improved management that are based on solid principles derived from extensive experience which may protect against the problems derived from the vague and subjective nature of pain symptoms. Optimal treatment of chronic pain may be assisted by three paradigms: (1) an adequate model of appraisal, (2) treatment focused on pathophysiology (whether physical, psychosocial, or some combination of these), and (3) frequent reassessment of total social function. By these approaches, contribution to drug abuse, diversion, and life deterioration can be largely avoided. Whereas the emphasis here is pharmacological management, the principles may be more widely applied to other therapies of chronic pain.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 2002, NAT CANC CONTR PROGR, V2nd
[2]  
Balevi B, 1996, J Can Dent Assoc, V62, P56
[3]   Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity [J].
Barsky, AJ ;
Orav, EJ ;
Bates, DW .
ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (08) :903-910
[4]  
*CHIC AM MED ASS, 1990, GUID EV PERM IMP
[5]   Trends in abuse of OxyContin® and other opioid analgesics in the United States:: 2002-2004 [J].
Cicero, TJ ;
Inciardi, JA ;
Muñoz, A .
JOURNAL OF PAIN, 2005, 6 (10) :662-672
[6]  
COLVI R, 1995, PRESCRIPTION DRUG AB
[7]  
*COMM EP WORK GROU, 2005, EP TRENDS DRUG AB
[8]  
CROSSE M, 2003, GAO04110
[9]  
CZECHOWICZ D, PRESCRIPTION DRUG AB
[10]   The lived experience of cardiac disease [J].
Margolis, Stephen A. .
AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (09) :645-645